Literature DB >> 2616814

T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications.

W M Mendenhall1, J T Parsons, S P Stringer, N J Cassisi, R R Million.   

Abstract

The purpose of this paper is to analyze the time factor and the proportion of the total dose delivered with external-beam irradiation versus interstitial implant in 42 patients with previously untreated T2 squamous cell carcinoma of the oral tongue managed with irradiation alone between 1964 and 1986. All patients had a 2-year minimum follow-up, and 93% were observed for at least 5 years. Seven patients died within 2 years of treatment with the primary site continuously disease-free and were excluded from analysis of local control. All patients were included in the analysis of complications. Patients were staged according to the 1983 AJCC staging system. Treatment was delivered with interstitial implant alone (4 patients), external-beam radiotherapy and implant (34 patients), or external-beam radiotherapy alone (4 patients). The following are the rates of local control with radiotherapy and ultimate local control, including patients successfully salvaged after a local recurrence: 21/35 (60%) and 26/35 (74%). In the group of patients treated with external-beam radiotherapy and an interstitial implant, local control was 12/16 (75%) for an implant plus less than or equal to 3000 cGy external-beam radiotherapy compared with 6/15 (40%) for an implant plus greater than 3000 cGy external-beam radiotherapy. For the entire group of patients, local control was 16/21 (76%) if the treatment time was less than 40 days and 5/14 (36%) if the overall treatment time was greater than 40 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2616814     DOI: 10.1016/0167-8140(89)90039-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer?

Authors:  W M Mendenhall; K I Bland; E M Copeland; G E Summers; W W Pfaff; W W Souba; R R Million
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

2.  Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines.

Authors:  Rajendra Bhalavat; Ashwini Budrukkar; Sarbani Ghosh Laskar; Dayanand Sharma; Ashutosh Mukherji; Manish Chandra; Umesh Mahantshetty; Vibhay Pareek; Pratibha Bauskar; Sonali Saraf
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

Review 3.  Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

Authors:  José A González Ferreira; Javier Jaén Olasolo; Ignacio Azinovic; Branislav Jeremic
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-04

4.  Compliance to therapy-elderly head and neck carcinoma patients.

Authors:  Aman Sharma; Renu Madan; Rajeev Kumar; Prem Sagar; Vineet K Kamal; Alok Thakar; Atul Sharma; Bidhu K Mohanti
Journal:  Can Geriatr J       Date:  2014-09-05

Review 5.  Current Role of Radiotherapy in the Management of Oral Cavity Squamous Cell Carcinoma.

Authors:  William M Mendenhall; Adam L Holtzman; Roi Dagan; Curtis M Bryant; Kathryn E Hitchcock; Robert J Amdur; Rui P Fernandes
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.